IN2003MU00504A - - Google Patents
Info
- Publication number
- IN2003MU00504A IN2003MU00504A IN504MU2003A IN2003MU00504A IN 2003MU00504 A IN2003MU00504 A IN 2003MU00504A IN 504MU2003 A IN504MU2003 A IN 504MU2003A IN 2003MU00504 A IN2003MU00504 A IN 2003MU00504A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN504MU2003 IN2003MU00504A (de) | 2003-06-05 | 2003-06-05 | |
EP04770652A EP1633330B1 (de) | 2003-06-05 | 2004-05-14 | Osmo-mikroverschlossene zubereitung mit verlängerter freisetzung von venlafaxine |
ES04770652T ES2286676T3 (es) | 2003-06-05 | 2004-05-14 | Formulacion osmomicrosellada de liberacion prolongada. |
PCT/IN2004/000133 WO2004108117A2 (en) | 2003-06-05 | 2004-05-14 | Extended release osmo-microsealed formulation comprising venlafaxine |
AT04770652T ATE358472T1 (de) | 2003-06-05 | 2004-05-14 | Osmo-mikroverschlossene zubereitung mit verlängerter freisetzung von venlafaxine |
US10/563,631 US20070110808A1 (en) | 2003-06-05 | 2004-05-14 | Extended release osmo-microsealed formulation |
DE602004005709T DE602004005709T2 (de) | 2003-06-05 | 2004-05-14 | Osmo-mikroverschlossene zubereitung mit verlängerter freisetzung von venlafaxine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN504MU2003 IN2003MU00504A (de) | 2003-06-05 | 2003-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2003MU00504A true IN2003MU00504A (de) | 2005-05-13 |
Family
ID=33495860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN504MU2003 IN2003MU00504A (de) | 2003-06-05 | 2003-06-05 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070110808A1 (de) |
EP (1) | EP1633330B1 (de) |
AT (1) | ATE358472T1 (de) |
DE (1) | DE602004005709T2 (de) |
ES (1) | ES2286676T3 (de) |
IN (1) | IN2003MU00504A (de) |
WO (1) | WO2004108117A2 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
CN102716101A (zh) | 1999-10-29 | 2012-10-10 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
EP2283829A1 (de) | 2000-10-30 | 2011-02-16 | Euro-Celtique S.A. | Hydrocodon-Formulierungen mit gesteuerter Freisetzung |
CA2595988A1 (en) | 2005-01-27 | 2006-08-03 | Alembic Limited | Extended release formulation of levetiracetam |
JP5095615B2 (ja) | 2005-06-27 | 2012-12-12 | バリアント・インターナショナル・(バルバドス)・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ | ブプロピオン塩の放出調整製剤 |
UA91376C2 (ru) * | 2005-08-24 | 2010-07-26 | Рубикон Рисеч Пвт Лтд. | Рецептура с контролируемым высвобождением |
EP2001450B1 (de) * | 2006-03-31 | 2019-01-30 | Rubicon Research Private Limited | Direkt komprimierbares gemisch für im mund zerfallende tabletten |
GB0610570D0 (en) * | 2006-05-27 | 2006-07-05 | Pliva Istrazivanje I Razvoj D | Novel formulation |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
EP2101738A2 (de) * | 2006-12-21 | 2009-09-23 | Mallinckrodt Inc. | Zusammensetzung und verfahren zur herstellung von im mund zerfallenden tabletten |
US20080245273A1 (en) * | 2007-04-05 | 2008-10-09 | Jouko Vyorkka | Hydrophobic coatings |
WO2009155488A2 (en) * | 2008-06-19 | 2009-12-23 | Segrub, Llc | Novel oxalate salt and crystal of o-desmethylvenlafaxine |
US20100209489A1 (en) * | 2009-02-04 | 2010-08-19 | Supernus Pharmaceuticals, Inc. | Formulations of desvenlafaxine |
JP5055397B2 (ja) * | 2010-03-10 | 2012-10-24 | 株式会社ユニックスジャパン | 歯科用成形体、及び歯科用樹脂材料 |
WO2011143120A1 (en) | 2010-05-11 | 2011-11-17 | Cima Labs Inc. | Alcoholres i stant metoprolol - containing extended - release oral dosage forms |
WO2011143119A1 (en) * | 2010-05-11 | 2011-11-17 | Cima Labs Inc. | Alcohol-resistant extended release dosage forms comprising venlafaxine |
US20150275167A1 (en) * | 2014-03-28 | 2015-10-01 | Corning Incorporated | Composition and method for cell culture sustained release |
CN106236739B (zh) * | 2016-07-27 | 2019-06-07 | 上海宣泰生物科技有限公司 | 含有叶黄素/叶黄素酯的组合物及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
CA2216215A1 (en) * | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6572890B2 (en) * | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
-
2003
- 2003-06-05 IN IN504MU2003 patent/IN2003MU00504A/en unknown
-
2004
- 2004-05-14 WO PCT/IN2004/000133 patent/WO2004108117A2/en active IP Right Grant
- 2004-05-14 EP EP04770652A patent/EP1633330B1/de active Active
- 2004-05-14 DE DE602004005709T patent/DE602004005709T2/de not_active Expired - Fee Related
- 2004-05-14 AT AT04770652T patent/ATE358472T1/de not_active IP Right Cessation
- 2004-05-14 ES ES04770652T patent/ES2286676T3/es active Active
- 2004-05-14 US US10/563,631 patent/US20070110808A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE358472T1 (de) | 2007-04-15 |
DE602004005709D1 (de) | 2007-05-16 |
DE602004005709T2 (de) | 2008-01-24 |
WO2004108117A3 (en) | 2005-09-15 |
US20070110808A1 (en) | 2007-05-17 |
WO2004108117A2 (en) | 2004-12-16 |
ES2286676T3 (es) | 2007-12-01 |
EP1633330A2 (de) | 2006-03-15 |
EP1633330B1 (de) | 2007-04-04 |